Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.191
-0.009 (-4.60%)
At close: Apr 28, 2026, 4:00 PM EDT
0.195
+0.004 (2.31%)
Pre-market: Apr 29, 2026, 7:12 AM EDT
Ernexa Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 1.88 | 1.73 | 7.58 | 11.45 | 16.99 | Upgrade
|
| Cash & Short-Term Investments | 1.88 | 1.73 | 7.58 | 11.45 | 16.99 | Upgrade
|
| Cash Growth | 8.96% | -77.18% | -33.82% | -32.61% | 942.02% | Upgrade
|
| Other Receivables | 0.85 | 0.44 | 0.43 | 0.95 | 0.68 | Upgrade
|
| Receivables | 0.85 | 0.44 | 0.43 | 0.95 | 0.68 | Upgrade
|
| Prepaid Expenses | 0.4 | 0.19 | 1.6 | 1.28 | 1.1 | Upgrade
|
| Total Current Assets | 3.13 | 2.35 | 9.6 | 13.68 | 18.77 | Upgrade
|
| Property, Plant & Equipment | 0.55 | 0.76 | 33.27 | 1.27 | 3.24 | Upgrade
|
| Long-Term Investments | - | - | - | 0.06 | 1 | Upgrade
|
| Goodwill | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 5.99 | Upgrade
|
| Other Long-Term Assets | 0.11 | 0.12 | 4.22 | 5.23 | 0.49 | Upgrade
|
| Total Assets | 5.83 | 5.27 | 49.13 | 22.28 | 31.53 | Upgrade
|
| Accounts Payable | 1.13 | 1.72 | 1.07 | 1.62 | 1.76 | Upgrade
|
| Accrued Expenses | 0.56 | 0.68 | 2.88 | 4.1 | 1.01 | Upgrade
|
| Current Portion of Leases | 0.21 | 0.21 | 2.22 | 0.3 | 0.43 | Upgrade
|
| Current Income Taxes Payable | 0 | 0 | 0 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | 0.19 | - | - | Upgrade
|
| Other Current Liabilities | 1.21 | 0.32 | 0.22 | 1.64 | 0.49 | Upgrade
|
| Total Current Liabilities | 3.11 | 2.94 | 6.57 | 7.65 | 3.68 | Upgrade
|
| Long-Term Debt | - | - | 6.77 | - | - | Upgrade
|
| Long-Term Leases | 0.28 | 0.48 | 32.85 | 0.89 | 2.3 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 0.39 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.04 | 0.15 | 0.31 | 1.63 | 0.05 | Upgrade
|
| Total Liabilities | 3.43 | 3.57 | 46.9 | 10.17 | 6.02 | Upgrade
|
| Common Stock | 0.04 | 0.02 | 0.03 | 0.03 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 248 | 233.22 | 189.19 | 177.38 | 166.19 | Upgrade
|
| Retained Earnings | -245.64 | -231.54 | -186.98 | -165.3 | -140.7 | Upgrade
|
| Total Common Equity | 2.4 | 1.7 | 2.23 | 12.11 | 25.5 | Upgrade
|
| Shareholders' Equity | 2.4 | 1.7 | 2.23 | 12.11 | 25.5 | Upgrade
|
| Total Liabilities & Equity | 5.83 | 5.27 | 49.13 | 22.28 | 31.53 | Upgrade
|
| Total Debt | 0.49 | 0.68 | 41.84 | 1.18 | 2.72 | Upgrade
|
| Net Cash (Debt) | 1.39 | 1.05 | -34.27 | 10.26 | 14.26 | Upgrade
|
| Net Cash Growth | 33.40% | - | - | -28.03% | - | Upgrade
|
| Net Cash Per Share | 0.22 | 1.15 | -96.73 | 50.46 | 98.81 | Upgrade
|
| Filing Date Shares Outstanding | 29.15 | 3.48 | 0.36 | 0.34 | 0.19 | Upgrade
|
| Total Common Shares Outstanding | 7.85 | 3.43 | 0.36 | 0.34 | 0.17 | Upgrade
|
| Working Capital | 0.02 | -0.59 | 3.03 | 6.03 | 15.09 | Upgrade
|
| Book Value Per Share | 0.31 | 0.50 | 6.19 | 35.42 | 147.07 | Upgrade
|
| Tangible Book Value | 0.36 | -0.34 | 0.19 | 10.06 | 23.46 | Upgrade
|
| Tangible Book Value Per Share | 0.05 | -0.10 | 0.52 | 29.44 | 135.28 | Upgrade
|
| Machinery | 0.22 | 0.26 | 0.33 | 0.27 | 0.41 | Upgrade
|
| Leasehold Improvements | 0.07 | - | 0.27 | - | 0.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.